Reference
Kuiper JL, et al. Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor. Journal of Clinical Pathology 68: 320-1, No. 4, Feb 2015. Available from: URL: http://doi.org/10.1136/jclinpath-2015-202866 - Netherlands
Rights and permissions
About this article
Cite this article
Erlotinib. Reactions Weekly 1577, 115 (2015). https://doi.org/10.1007/s40278-015-10528-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-10528-5